Hims & Hers Health shares rose 1% in pre-market trading, snapping a 13-week losing streak. The rebound comes despite JPMorgan sharply reducing its stake in the telehealth provider to 3.8 million shares, a roughly 14% reduction. The remaining stake is now below the 5% disclosure threshold. The stock has been under pressure due to regulatory scrutiny over weight-loss drugs.